- $859.41m
- $682.20m
- $379.81m
Annual cashflow statement for CareDx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -30.7 | -76.6 | -190 | 52.5 | -21.4 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 43.5 | 54 | 50.9 | 73.6 | 44.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -39.6 | -14 | 106 | -102 | 3.81 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -19.3 | -25.2 | -18.4 | 38 | 42 |
| Capital Expenditures | -20.3 | -24.3 | -9.24 | -6.48 | -6.59 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 68 | -204 | 49.7 | 6 | 8.75 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 47.7 | -229 | 40.4 | -0.483 | 2.16 |
| Financing Cash Flow Items | -18.1 | -8.56 | -3.68 | -15.4 | -13.6 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 186 | -4.54 | -29.6 | -5.61 | -93.4 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 214 | -258 | -7.66 | 32.5 | -49.3 |